Samsung's venture investment unit is considering investing in California-based medical device startup, Exo, in a round that may reach $100 million.
The funding round, led by Sands Capital, Bold Capital, and Qubit Health Capital, is set to bring Imar Ishrak, chairman of Qubit, onto Exo's board.
Exo, established in 2015, specializes in handheld medical imaging devices merging AI, medical imaging, and silicon technology for ultrasound like lung scans or echocardiograms.
Exo previously secured over $320 million from investors such as RA Capital Management, BlackRock, Sands Capital, Intel, Sony, and Avidity Partners, with a recent $220 million Series C funding round in 2021.